General intracellular components of viable leukocytes

General intracellular components of viable leukocytes refers to the collective internal molecular environment of white blood cells, including cytoplasmic proteins, organelles, and nucleic acids (StatPearls, 2023). While not a specific therapeutic target, these components serve as the site of action for certain diagnostic radiopharmaceuticals used in nuclear medicine imaging, such as Indium-111 oxine and Technetium-99m exametazime (FDA, 2013). These agents are employed to label autologous leukocytes ex vivo; the lipophilic complexes penetrate the cell membrane and the radioactive moiety becomes trapped within the cell by binding to various intracellular structures (Peters, 1998). This labeling allows for the scintigraphic localization of inflammatory processes, infections, or abscesses where leukocytes naturally accumulate. Because this term encompasses a vast array of distinct molecules rather than a single defined protein or pathway, it is generally considered too non-specific for drug discovery purposes. The viability of the leukocytes is critical, as the mechanism of uptake and retention often depends on intact cellular membranes and active metabolic processes.

Other names

Intracellular leukocyte componentsCytoplasmic leukocyte proteinsIntracellular white blood cell components

Radiopharmaceutical complexes diffuse passively across the plasma membrane of viable leukocytes, where the radioactive isotope dissociates or is metabolically trapped, subsequently binding non-specifically to various intracellular proteins and organelles (StatPearls, 2023; Peters, 1998).